SCHEMBL491313

SCHEMBL491313

c1ccc(/N=N/C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
TSHR P16473 4/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
TDP1 Q9NUW8 4/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
MAPK1 P28482 3/20 0.37
TRPA1 O75762 2/20 0.37
HSD17B10 Q99714 1/20 0.37
KCNN4 O15554 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491314 1.00 ALDH1A1 (0.52) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL11298591 0.85 MEN1 (0.47) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL11293444 0.85 MEN1 (0.59) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL11298593 0.85 MEN1 (0.47) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL11293876 0.85 TSHR (0.39) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL11293443 0.85 MEN1 (0.59) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL10887248 0.82 MEN1 (0.46) TSHRMEN1KMT2AMAPTNPC1
SCHEMBL10887240 0.82 MEN1 (0.46) TSHRMEN1KMT2AMAPTNPC1
SCHEMBL7545359 0.80 MEN1 (0.53) ALDH1A1MEN1KMT2AMAPTNPC1
SCHEMBL7113947 0.80 MEN1 (0.38) ALDH1A1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459193-B2 Method and kit for non-destructive in situ repair (relining) of deteriorated pipelines APPLIED RESIN S L (ES) 2025-11-04 US claimed
EP-4225557-B1 METHOD AND KIT FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES APPLIED RESIN S L (ES) 2025-02-19 EP claimed
US-11865374-B2 Functionalized polymers EVONIK OPERATIONS GMBH (DE) 2024-01-09 US claimed
US-20230373154-A1 Method and kit for non-destructive in situ repair (relining) of deteriorated pipelines APPLIED RESIN S.L. (ES) 2023-11-23 US claimed
US-20230312987-A1 Method, kit and composition for non-destructive in situ repair or relining of deteriorated pipelines with a dual use system APPLIED RESIN S.L. (ES) 2023-10-05 US claimed
US-20230312791-A1 FUNCTIONALIZED POLYMERS EVONIK OPERATIONS GMBH (DE) 2023-10-05 US claimed
EP-4253819-A1 METHOD, KIT AND COMPOSITION FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES WITH A DUAL USE SYSTEM Applied Resin S.L. (ES) 2023-10-04 EP claimed
EP-4225557-A1 METHOD AND KIT FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES Applied Resin S.L. (ES) 2023-08-16 EP claimed
EP-4200343-A1 FUNCTIONALIZED POLYMERS Evonik Operations GmbH (DE) 2023-06-28 EP claimed
US-20230149849-A1 TUNABLE, RAPID UPTAKE, AMINOPOLYMER AEROGEL SORBENT FOR DIRECT AIR CAPTURE OF CO2 Genesee Valley Innovations, LLC 2023-05-18 US claimed
US-20020133072-A1 Graft polymerization of substrate surfaces ANGIOTECH BIOCOATINGS CORP. 2002-09-19 US claimed
US-6372930-B1 POLYMERIC LIGAND HAVING UNITS CONTAINING AT LEAST ONE BRIDGED CYCLOPENTADIENYL-TYPE GROUP INCLUDING AT LEAST ONE FLUORENYL-TYPE GROUP PHILLIPS PETROLEUM COMPANY 2002-04-16 US claimed
US-6361928-B1 Method of defining a mask pattern for a photoresist layer in semiconductor fabrication UNITED MICROELECTRONICS CORP. (TW) 2002-03-26 US claimed
EP-1103046-A2 ORGANIC DYE-IN-POLYMER (DIP) MEDIUM FOR WRITE-ONCE-READ-MANY (WORM) OPTICAL DISCS WITH FLUORESCENT READING OMD Devices LLC (US) 2001-05-30 EP claimed
US-6057410-A COMPLEXING FOR POLYMERIZATION CATALYSTS A PENTADIENYL LIGAND AND POLYMERIZATION WITH INITIATORS PHILLIPS PETROLEUM COMPANY (US) 2000-05-02 US claimed
WO-1999059142-A2 ORGANIC DYE-IN-POLYMER (DIP) MEDIUM FOR WRITE-ONCE-READ-MANY (WORM) OPTICAL DISCS WITH FLUORESCENT READING OMD DEVICES LLC (US) 1999-11-18 WO claimed
US-5371238-A Reacting 1-/n-alkenyl/-azacycloalkan-2-one with alkyl mercaptan using free radical initiator, reducing, distilling to purify HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1994-12-06 US claimed
US-4618647-A TWO POLYMERIZATION CATALYSTS UNION CARBIDE CORP. (US) 1986-10-21 US claimed
US-4477599-A INCLUDING ACTIVATOR, FILLER, AND BLOWING AGENTS HIROSUKE KOJIMA (JP) 1984-10-16 US claimed
US-4097404-A POLYMERIZATION, COACERVATION XEROX CORPORATION (US) 1978-06-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11865374-B2 Functionalized polymers PUF60, PARN, PARG ALDH1A1 2598/4885TSHR 2538/4885MEN1 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.